Phase 3 Crohns Disease Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche425 enrolled167 locationsNCT06819891
Recruiting
Phase 3
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Crohns Disease
Janssen Research & Development, LLC196 enrolled38 locationsNCT06663332
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche600 enrolled355 locationsNCT06819878
Not Yet Recruiting
Phase 3
A Phase 3 Study of Abatacept in Patients With Active Crohn's Disease
Crohns Disease
Bristol-Myers Squibb689 enrolled1 locationACTRN12607000002482